Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!
Top 5 Fast-growings companies in Liquid biopsy by Most Patent Filing In 3 Years in the South Korea in 2022
The Liquid biopsy top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 3 Years Liquid biopsy Fast-growings in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
A liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. Therefore, it can also be done more frequently which can better track tumors and mutations over a duration of time. It may also be used to validate the efficiency of a cancer treatment drug by taking multiple liquid biopsy samples in the span of a few weeks. The technology may also prove beneficial for patients after treatment to monitor relapse.